Spero Therapeutics Inc (SPRO) Insider Trading
- $20,578,301.34
- $11,631,477.57
- Feb. 5, 2025
- Aquilo Capital Management, Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 6, 2017 | Major Shareholder | 428,571 | $14.00 | Buy | $5,999,994.00 | |
| March 11, 2013 | CEO | 15,000 | $1.53 | Buy | $22,950.00 | |
| Dec. 28, 2012 | Major Shareholder | 22,693 | $1.19 | Buy | $27,004.67 | |
| Dec. 24, 2012 | President | 2,000 | $2.40 | Buy | $4,800.00 | |
| Sept. 5, 2012 | Director | 4,600 | $1.90 | Buy | $8,740.00 | |
| Aug. 30, 2012 | CEO | 5,000 | $1.82 | Buy | $9,100.00 |
Insiders are both buying and selling Spero Therapeutics Inc stock.
The insider traders at Spero Therapeutics Inc are: Aquilo Capital Management, Llc, Ankit Mahadevia, Sath Shukla, Timothy Keutzer, Cristina Larkin, Allen S Greene, Joel Sendek, Plc Glaxosmithkline, John J Gorman, Kamal Hamed, Zohar Ben-Dov, Esther Rajavelu, Jack Fingerhut, and Casper Breum
The most active insider trader at Spero Therapeutics Inc is Aquilo Capital Management, Llc with 20 trades.
Aquilo Capital Management, Llc has sold the most Spero Therapeutics Inc stock with a total value of $14,941,893.02.
Aquilo Capital Management, Llc has bought the most Spero Therapeutics Inc stock with a total value of $10,622,892.15.
The most recent insider trade for Spero Therapeutics Inc was on Feb. 5, 2025.
The single biggest insider buy for Spero Therapeutics Inc was from Plc Glaxosmithkline with a total value of $5,999,994.00 on Nov. 6, 2017.
The single biggest insider sell for Spero Therapeutics Inc was from Aquilo Capital Management, Llc with a total value of $4,279,041.00 on Sept. 22, 2022.